North America Drug Safety & Pharmacovigilance Software Market Size and Strategic Forecast to 2031
Pharmacovigilance and Drug Safety Software ensures compliance with evolving electronic reporting standards like E2B(R3) across different geographic markets. The pharmacovigilance and drug safety software market was valued at US$ 1.97 billion in 2021 and is expected to reach US$ 3.29 billion by 2031. The market is expected to register a CAGR of 5.9% in 2023–2031. What is driving the...
0 Commentarios 0 Acciones 82 Views 0 Vista previa